Essex Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-63,754
| Closed | -$3.21M | – | 526 |
|
|
2018
Q3 | $3.21M | Buy |
63,754
+2,042
| +3% | +$103K | 0.38% | 70 |
|
|
2018
Q2 | $3.69M | Buy |
61,712
+59
| +0.1% | +$3.53K | 0.46% | 56 |
|
|
2018
Q1 | $2.82M | Sell |
61,653
-3,508
| -5% | -$161K | 0.37% | 78 |
|
|
2017
Q4 | $2.6M | Buy |
65,161
+1,917
| +3% | +$76.4K | 0.34% | 83 |
|
|
2017
Q3 | $2.53M | Sell |
63,244
-13,535
| -18% | -$541K | 0.34% | 77 |
|
|
2017
Q2 | $3.31M | Buy |
76,779
+17,417
| +29% | +$751K | 0.47% | 49 |
|
|
2017
Q1 | $1.86M | Buy |
59,362
+8,920
| +18% | +$279K | 0.29% | 100 |
|
|
2016
Q4 | $1.27M | Buy |
50,442
+3,267
| +7% | +$82.5K | 0.21% | 128 |
|
|
2016
Q3 | $1.17M | Sell |
47,175
-50,688
| -52% | -$1.25M | 0.19% | 134 |
|
|
2016
Q2 | $1.99M | Sell |
97,863
-8,542
| -8% | -$174K | 0.33% | 81 |
|
|
2016
Q1 | $1.62M | Buy |
106,405
+15,777
| +17% | +$241K | 0.28% | 85 |
|
|
2015
Q4 | $1.22M | Sell |
90,628
-5,403
| -6% | -$72.6K | 0.19% | 126 |
|
|
2015
Q3 | $1.35M | Buy |
96,031
+3,987
| +4% | +$55.9K | 0.22% | 104 |
|
|
2015
Q2 | $1.56M | Sell |
92,044
-1,937
| -2% | -$32.9K | 0.24% | 104 |
|
|
2015
Q1 | $1.14M | Sell |
93,981
-729
| -0.8% | -$8.81K | 0.16% | 136 |
|
|
2014
Q4 | $786K | Sell |
94,710
-14,420
| -13% | -$120K | 0.11% | 188 |
|
|
2014
Q3 | $948K | Buy |
+109,130
| New | +$948K | 0.15% | 162 |
|